Approval · Notice of Compliance 30782 · 2023
VAXCHORA: Notice of Compliance 30782
Issued May 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30782
- Date
- May 18, 2023
- Company
- Emergent Travel Health Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAXCHORA | 02538164 | Marketed |
Medicinal ingredients
- VIBRIO CHOLERAE, STRAIN CVD 103-HGR, LIVE 400,000,000 UNIT per DOSE